Zanamivir should be inhaled, not nebulisedBMJ 2010; 340 doi: http://dx.doi.org/10.1136/bmj.c131 (Published 13 January 2010) Cite this as: BMJ 2010;340:c131
- Barry A Eagel, clinical safety director1
- 1Clinical Monitoring Research Programme, SAIC-Frederick, NCI-Frederick, 5705 Industry Lane, Frederick, MD 21702-1201, USA
Jefferson and colleagues say that nebulisation is the route of administration for zanamivir.1 However, prescribers should be aware that the approved use of zanamivir in the United States and European Union …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial